{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:52Z","timestamp":1792800712939,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although research on Medications for Opioid Use Disorder (MOUD) in carceral settings has grown, it has largely focused on the implementation of medication delivery or on substance use outcomes in the community. However, the introduction of new programs or the expansion of treatment services in criminal legal settings can have both direct and indirect consequences on other treatment programs and correctional operations within jails. Mental health and substance use disorders frequently co-occur, and their psychosocial treatment components often overlap. We examined how the implementation of MOUD in all jails across Massachusetts impacted the mental health services operating within the jails and the requirements for substance use counseling alongside MOUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted semi-structured interviews (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200947) and focus groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200942) with staff from 13 county jails as part of an implementation of MOUD in jails study. Using deductive and inductive coding, all transcripts were double-coded and analyzed using a modified framework method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified five key themes about the perceived impact of MOUD on mental health and substance use counseling services. First, MOUD implementation was perceived to reduce acute mental health crises, such as risk for suicide, and the demand on mental health services at intake to the facility. Second, staff perceptions about the effectiveness of MOUD as a stand-alone treatment influenced their decisions about the need for and interpretation of substance use counseling requirements. Third, the required components of substance use counseling created a need for additional staff, which exacerbated the existing shortage of mental health staff. Fourth, infrastructure limitations and privacy needs made the delivery of substance use counseling logistically challenging in jail settings. Finally, MOUD implementation increased interdisciplinary collaboration in some jails by requiring medical, mental health, and substance use providers to work together to resolve the needs of incarcerated individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>As jails aim to meet regulatory requirements for MOUD, they will need to manage potential staffing shortages, infrastructure constraints, and shifts in the mental health and substance use counseling services. Guidelines for implementing MOUD in carceral settings should also consider the unintended consequences of MOUD on other behavioral health services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-025-00641-3","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:24:25Z","timestamp":1766424265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-3604","authenticated-orcid":false,"given":"Ekaterina","family":"Pivovarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Bovell Ammon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-9957","authenticated-orcid":false,"given":"Elizabeth A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"9","key":"641_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2105\/ajph.2024.307723","volume":"114","author":"K Hill","year":"2024","unstructured":"Hill K, Bodurtha PJ, Winkelman TNA, Howell BA. Postrelease risk of overdose and all-cause death among persons released from jail or prison: Minnesota, March 2020\u2013December 2021. Am J Public Health. 2024;114(9):913\u201322. https:\/\/doi.org\/10.2105\/ajph.2024.307723.","journal-title":"Am J Public Health"},{"key":"641_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109655","author":"AW O\u2019Connor","year":"2022","unstructured":"O\u2019Connor AW, Sears JM, Fulton-Kehoe D. Overdose and substance-related mortality after release from prison in Washington state: 2014\u20132019. Drug Alcohol Depend. 2022;241:109655. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109655.","journal-title":"Drug Alcohol Depend"},{"key":"641_CR3","doi-asserted-by":"publisher","unstructured":"Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data. J Subst Use Addict Treat. 2023;147. https:\/\/doi.org\/10.1016\/j.josat.2023.208971.","DOI":"10.1016\/j.josat.2023.208971"},{"key":"641_CR4","unstructured":"Logan JL, LaBelle JR, Weizman S. Medications for opioid use disorder in US jails and prisons: status update. O\u2019Neill institute for national and global health law at Georgetown university law center; 2024."},{"issue":"9","key":"641_CR5","doi-asserted-by":"publisher","first-page":"e2434704","DOI":"10.1001\/jamanetworkopen.2024.34704","volume":"3","author":"E Flanagan Balawajder","year":"2024","unstructured":"Flanagan Balawajder E, Ducharme L, Taylor BG, et al. Factors associated with the availability of medications for opioid use disorder in US jails. JAMA Netw Open Sep. 2024;3(9):e2434704. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.34704.","journal-title":"JAMA Netw Open Sep"},{"key":"641_CR6","doi-asserted-by":"publisher","unstructured":"Evans EA, Stopka TJ, Pivovarova E, et al. Massachusetts justice community opioid innovation network (MassJCOIN). J Subst Abuse Treat. 2021;128. https:\/\/doi.org\/10.1016\/j.jsat.2021.108275.","DOI":"10.1016\/j.jsat.2021.108275"},{"key":"641_CR7","doi-asserted-by":"publisher","first-page":"263348952211012","DOI":"10.1177\/26334895221101214","volume":"3","author":"A Ludwig","year":"2022","unstructured":"Ludwig A, Monico LB, Blue T, Gordon MS, Schwartz RP, Mitchell SG. Development and use of a checklist for the implementation of medication for opioid use disorder in jails Implement Res Pract. 2022;3:26334895221101214. https:\/\/doi.org\/10.1177\/26334895221101214.","journal-title":"Implement Res Pract"},{"issue":"1","key":"641_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/00220426231196304","volume":"55","author":"KJ Clark","year":"2025","unstructured":"Clark KJ, Vechinski J, Molfenter T, Taxman FS. Cascade of care in the legal system: best practices and goals for agencies providing care to patients concurrently navigating substance use disorders and criminal legal involvement. J Drug Issues. 2025;55(1):64\u201388. https:\/\/doi.org\/10.1177\/00220426231196304.","journal-title":"J Drug Issues"},{"issue":"1","key":"641_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/jchc.23.08.0065","volume":"2024\/02\/01","author":"M McGladrey","year":"2023","unstructured":"McGladrey M, Kelsch J, Lofwall MR, Fanucchi LC, Walsh SL, Oser CB. Get it in writing: how to make medications for opioid use disorder available during incarceration J Correctional Health Care. 2023;30(1):3\u20136. https:\/\/doi.org\/10.1089\/jchc.23.08.0065.","journal-title":"J Correctional Health Care"},{"key":"641_CR10","doi-asserted-by":"publisher","unstructured":"Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022;138. https:\/\/doi.org\/10.1016\/j.jsat.2022.108746.","DOI":"10.1016\/j.jsat.2022.108746"},{"key":"641_CR11","doi-asserted-by":"publisher","unstructured":"Martin RA, Berk J, Rich JD, Kang A, Fritsche J, Clarke JG. Use of long-acting injectable buprenorphine in the correctional setting. J Subst Abuse Treat. 2022;142. https:\/\/doi.org\/10.1016\/j.jsat.2022.108851.","DOI":"10.1016\/j.jsat.2022.108851"},{"issue":"3","key":"641_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/add.16071","volume":"118","author":"S Lim","year":"2023","unstructured":"Lim S, Cherian T, Katyal M, et al. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011\u201317. Addiction. 2023;118(3):459\u201367. https:\/\/doi.org\/10.1111\/add.16071.","journal-title":"Addiction"},{"issue":"1","key":"641_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40352-023-00209-w","volume":"11","author":"L Cates","year":"2023","unstructured":"Cates L, Brown AR. Medications for opioid use disorder during incarceration and post-release outcomes. Health Justice. 2023;11(1):4.","journal-title":"Health Justice"},{"issue":"Suppl 1","key":"641_CR14","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.drugalcdep.2009.01.003","volume":"1","author":"DW Young","year":"2009","unstructured":"Young DW, Farrell JL, Henderson CE, Taxman FS. Filling service gaps: providing intensive treatment services for offenders. Drug Alcohol Depend Aug. 2009;1(Suppl 1):S33\u201342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.01.003.","journal-title":"Drug Alcohol Depend Aug"},{"key":"641_CR15","doi-asserted-by":"publisher","unstructured":"Pourtaher E, Gelberg KH, Fallico M, Ellendon N, Li S. Expanding access to medication for opioid use disorder (MOUD) in jails: a comprehensive program evaluation. J Subst Use Addict Treat. 2024;161. https:\/\/doi.org\/10.1016\/j.josat.2023.209248.","DOI":"10.1016\/j.josat.2023.209248"},{"issue":"1","key":"641_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0032885519882326","volume":"100","author":"LM Salerno","year":"2020","unstructured":"Salerno LM, Zgoba KM. Disciplinary segregation and its effects on in-prison outcomes. Prison J. 2020;100(1):74\u201397.","journal-title":"Prison J"},{"issue":"1","key":"641_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2105\/ajph.2005.069336","volume":"97","author":"YI Hser","year":"2007","unstructured":"Hser YI, Teruya C, Brown AH, Huang D, Evans E, Anglin MD. Impact of california\u2019s proposition 36 on the drug treatment system: treatment capacity and displacement. Am J Public Health. 2007;97(1):104\u20139. https:\/\/doi.org\/10.2105\/ajph.2005.069336.","journal-title":"Am J Public Health Jan"},{"issue":"4","key":"641_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11414-008-9129-z","volume":"36","author":"N Niv","year":"2009","unstructured":"Niv N, Hamilton A, Hser YI. Impact of court-mandated substance abuse treatment on clinical decision making. J Behav Health Serv Res. 2009;36(4):505\u201316. https:\/\/doi.org\/10.1007\/s11414-008-9129-z.","journal-title":"J Behav Health Serv Res Oct"},{"issue":"2","key":"641_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1465-3362.2010.00216.x","volume":"30","author":"T Butler","year":"2011","unstructured":"Butler T, Indig D, Allnutt S, Mamoon H. Co-occurring mental illness and substance use disorder among Australian prisoners. Drug Alcohol Rev. 2011;30(2):188\u201394. https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00216.x.","journal-title":"Drug Alcohol Rev Mar"},{"issue":"4","key":"641_CR20","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1192\/bjo.2023.514","volume":"9","author":"N van Buitenen","year":"2023","unstructured":"van Buitenen N, Meijers J, van den Berg CJW, Harte JM. Investigating the prevalence of problematic substance use and mental disorders in a large sample of prisoners with mental illness: network analysis. BJPsych Open. 2023;9(4):e122\u2013122. https:\/\/doi.org\/10.1192\/bjo.2023.514.","journal-title":"BJPsych Open"},{"issue":"6","key":"641_CR21","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/S2468-2667(22)00093-7","volume":"7","author":"G Baranyi","year":"2022","unstructured":"Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis. Lancet Public Health. 2022;7(6):e557\u201368. https:\/\/doi.org\/10.1016\/S2468-2667(22)00093-7.","journal-title":"Lancet Public Health"},{"issue":"1","key":"641_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1037\/prj0000110","volume":"38","author":"K Houser","year":"2015","unstructured":"Houser K, Belenko S. Disciplinary responses to misconduct among female prison inmates with mental illness, substance use disorders, and co-occurring disorders. Psychiatr Rehabil J. 2015;38(1):24.","journal-title":"Psychiatr Rehabil J"},{"key":"641_CR23","doi-asserted-by":"publisher","unstructured":"Mundt AP, Baranyi G. The unhappy mental health triad: comorbid severe mental illnesses, personality disorders, and substance use disorders in prison populations. Original Research. Front Psychiat. 2020;11. https:\/\/doi.org\/10.3389\/fpsyt.2020.00804.","DOI":"10.3389\/fpsyt.2020.00804"},{"key":"641_CR24","doi-asserted-by":"publisher","unstructured":"Morris NP, West SG. Misconceptions about working in correctional psychiatry. J Am Acad Psychiatry Law Online. 2020;JAAPL003921\u201320. https:\/\/doi.org\/10.29158\/JAAPL.003921-20.","DOI":"10.29158\/JAAPL.003921-20"},{"key":"641_CR25","unstructured":"Office of the federal register. 42 CFR 8 - Medication assisted treatment for opioid use disorders. In: National Archives and Records Administration, editor. 2016."},{"key":"641_CR26","unstructured":"Research and development (RAND). Counseling co-requirement laws for office-based buprenorphine treatment. 2023."},{"key":"641_CR27","unstructured":"Department of health and human services. 42 CFR part 8 medications for the treatment of opioid use disorder. 2024."},{"issue":"12","key":"641_CR28","doi-asserted-by":"publisher","first-page":"e0244401","DOI":"10.1371\/journal.pone.0244401","volume":"15","author":"D Rice","year":"2020","unstructured":"Rice D, Corace K, Wolfe D, et al. Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: a systematic review with network meta-analyses. PLoS ONE. 2020;15(12):e0244401.","journal-title":"PLoS ONE"},{"key":"641_CR29","doi-asserted-by":"publisher","unstructured":"McHugh RK, Hilton BT, Chase AM, Griffin ML, Weiss RD. Do people with opioid use disorder and posttraumatic stress disorder benefit from Dding individual opioid drug counseling to buprenorphine? Drug Alcohol Depend. 2021;228:109084. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109084.","DOI":"10.1016\/j.drugalcdep.2021.109084"},{"issue":"6","key":"641_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/00952990.2020.1807559","volume":"1","author":"B Andraka-Christou","year":"2020","unstructured":"Andraka-Christou B, Atkins D. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff. Am J Drug Alcohol Abuse. 2020;1(6):749\u201360. https:\/\/doi.org\/10.1080\/00952990.2020.1807559.","journal-title":"Am J Drug Alcohol Abuse Nov"},{"key":"641_CR31","first-page":"117822182211038","volume":"16","author":"J Dickson-Gomez","year":"2022","unstructured":"Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. You\u2019re not supposed to be on it forever: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst Abuse: Res Treat. 2022;16:11782218221103859.","journal-title":"Subst Abuse: Res Treat"},{"key":"641_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","volume":"232","author":"EF Madden","year":"2019","unstructured":"Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 2019;232:324\u201331.","journal-title":"Soc Sci Med"},{"key":"641_CR33","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.ssmqr.2022.100161","volume":"2","author":"EF Madden","year":"2022","unstructured":"Madden EF, Barker KK, Guerra J, Villanueva C, Sulzer SH. Variation in intervention stigma among medications for opioid use disorder. SSM-Qualitative Res Health. 2022;2:100161.","journal-title":"SSM-Qualitative Res Health"},{"key":"641_CR34","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.dadr.2023.100211","volume":"10","author":"A Pfaff","year":"2024","unstructured":"Pfaff A, Cochran A, Vechinski J, Molfenter T, Zayas-Cab\u00e1n G. The association between attitudes and the provision of medications for opioid use disorder (MOUD) in united States jails. Drug Alcohol Depend Rep. 2024;10:100211.","journal-title":"Drug Alcohol Depend Rep"},{"key":"641_CR35","unstructured":"Oregon MHACBo. Research-based mental health professional competencies."},{"key":"641_CR36","unstructured":"Treatment CSA. Addiction counseling competencies: the knowledge, skills, and attitudes of professional practice. Technical Assistance Publication (TAP) Series; 2006."},{"key":"641_CR37","doi-asserted-by":"publisher","unstructured":"Lee TK. Addiction education and training for counselors: a qualitative study of five experts. J Addict Offend Counsel. 2014;35(2):67\u201380. https:\/\/doi.org\/10.1002\/j.2161-1874.2014.00027.x.","DOI":"10.1002\/j.2161-1874.2014.00027.x"},{"key":"641_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpr.2015.02.008","volume":"38","author":"M Romano","year":"2015","unstructured":"Romano M, Peters L. Evaluating the mechanisms of change in motivational interviewing in the treatment of mental health problems: a review and meta-analysis. Clin Psychol Rev. 2015;38:1\u201312. https:\/\/doi.org\/10.1016\/j.cpr.2015.02.008.","journal-title":"Clin Psychol Rev"},{"key":"641_CR39","doi-asserted-by":"publisher","unstructured":"Schwenker R, Dietrich CE, Hirpa S, et al. Motivational interviewing for substance use reduction. Cochrane Database Syst Reviews. 2023;(12). https:\/\/doi.org\/10.1002\/14651858.CD008063.pub3.","DOI":"10.1002\/14651858.CD008063.pub3"},{"issue":"1","key":"641_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38(1):4\u201323. https:\/\/doi.org\/10.1007\/s10488-010-0327-7.","journal-title":"Adm Policy Ment Health Jan"},{"issue":"1","key":"641_CR41","doi-asserted-by":"publisher","first-page":"A29","DOI":"10.1186\/1940-0640-10-S1-A29","volume":"2015\/02\/20","author":"D Knight","year":"2015","unstructured":"Knight D, Belenko S, Robertson A, et al. Designing the optimal JJ-TRIALS study: EPIS as a theoretical framework for selection and timing of implementation interventions. Addict Sci Clin Pract. 2015;10(1):A29. https:\/\/doi.org\/10.1186\/1940-0640-10-S1-A29.","journal-title":"Addict Sci Clin Pract"},{"key":"641_CR42","doi-asserted-by":"publisher","unstructured":"Ferguson WJ, Johnston J, Clarke JG, et al. Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails. Health Justice. 2019;7(1):19. https:\/\/doi.org\/10.1186\/s40352-019-0100-2.","DOI":"10.1186\/s40352-019-0100-2"},{"issue":"2","key":"641_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/10986111241265290","volume":"28","author":"B del Pozo","year":"2024","unstructured":"del Pozo B, Belenko S, Pivovarova E, Ray B, Martins KF, Taxman FS. Using implementation science to improve evidence-based policing: an introduction for researchers and practitioners. Police Q. 2024;28(2):182\u2013211. https:\/\/doi.org\/10.1177\/10986111241265290.","journal-title":"Police Q"},{"issue":"4","key":"641_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2307\/798843","volume":"12","author":"BG Glaser","year":"1965","unstructured":"Glaser BG. The constant comparative method of qualitative Analysis*. Soc Probl. 1965;12(4):436\u201345. https:\/\/doi.org\/10.2307\/798843.","journal-title":"Soc Probl"},{"key":"641_CR45","unstructured":"Dedoose version. 9.0.17. A web application for managing, analyzing, and presenting qualitative and mixed method research data. 2021. available online: https:\/\/www.dedoose.com\/. (accessed on 20 April. 2022)."},{"issue":"1","key":"641_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"2013\/09\/18","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117. https:\/\/doi.org\/10.1186\/1471-2288-13-117.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"641_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsat.2005.10.004","volume":"30","author":"LF Mangrum","year":"2006","unstructured":"Mangrum LF, Spence RT, Lopez M. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. J Subst Abuse Treat. 2006;30(1):79\u201384.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"641_CR48","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/dar.13651","volume":"2023\/07\/01","author":"C Glover-Wright","year":"2023","unstructured":"Glover-Wright C, Coupe K, Campbell AC, et al. Health outcomes and service use patterns associated with co-located outpatient mental health care and alcohol and other drug specialist treatment: a systematic review. Drug Alcohol Rev. 2023;42(5):1195\u2013219. https:\/\/doi.org\/10.1111\/dar.13651.","journal-title":"Drug Alcohol Rev"},{"key":"641_CR49","doi-asserted-by":"publisher","unstructured":"Pont J, St\u00f6ver H, Wolff H. Dual loyalty in prison health care. Am J Public Health. 2012;102(3):475\u2013480. https:\/\/doi.org\/10.2105\/AJPH.2011.300374.","DOI":"10.2105\/AJPH.2011.300374"},{"key":"641_CR50","doi-asserted-by":"publisher","unstructured":"Ryan DA, Montoya ID, Koutoujian PJ, et al. Budget impact tool for the incorporation of medications for opioid use disorder into jail\/prison facilities. J Subst Use Addict Treat. 2023;146. https:\/\/doi.org\/10.1016\/j.josat.2022.208943.","DOI":"10.1016\/j.josat.2022.208943"},{"key":"641_CR51","doi-asserted-by":"publisher","unstructured":"Ryan D, Ekanayake DL, Evans E, et al. Cost analysis of MOUD implementation and sustainability in Massachusetts jails. Health Justice. 2025;13(1):9. https:\/\/doi.org\/10.1186\/s40352-025-00321-z.","DOI":"10.1186\/s40352-025-00321-z"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00641-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:03:41Z","timestamp":1769047421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-025-00641-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00641-3","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Baystate Health IRB served as the single IRB and reviewed and approved all research activities. All participants provided informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}